Archive

• AXA IM Alts raises €1.9bn for European Life Sciences investments

  26 July 2021

  Following acquisition of boutique asset manager Kadans Science Partner

• Axa IMRA enters European life science sector with lab office firm acquisition

  26 November 2020

  Purchase is worth €500m, Insurance Asset Risk has learnt